# Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

> **NCT04926948** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 20 (actual)

## Conditions studied

- Pleural Mesothelial Neoplasm

## Interventions

- **OTHER:** Immunotherapy
- **OTHER:** Quality-of-Life Assessment
- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT04926948
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-12
- **Primary completion:** 2026-05-25
- **Final completion:** 2026-05-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04926948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04926948, "Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04926948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*